Clinical Trials Logo

Filter by:
NCT ID: NCT05778968 Recruiting - Clinical trials for End-tidal Carbon Dioxide

Etco2 Levels on the End-tidal Concentration of Sevoflurane

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

he assessment of adequate levels of anaesthesia traditionally relies not only on a patient's movement but also on the hemodynamic response (or both) to a surgical stimulus

NCT ID: NCT05778838 Recruiting - Septic Shock Clinical Trials

Midodrine Effect on the Mortality Rates in Septic Shock Patients

Start date: April 1, 2023
Phase: Phase 4
Study type: Interventional

Assessing the safety and efficacy of the adjunctive use of midodrine as a vasopressor in septic shock patients by measuring the difference in the mortality rates between control and intervention groups.

NCT ID: NCT05778305 Recruiting - Clinical trials for Effect of Drug in CABAG Patients

Effect of Dexmedetomidine on Left Ventricular Function in Coronary Artery Bypass Graft Surgery Outcome

CABAG
Start date: January 29, 2023
Phase: Early Phase 1
Study type: Interventional

50 patients of both sexes undergoing elective CABG surgery will be randomly divided into 2 groups, study group (Dex) group and control group (C) to determine the effect of dexmedetomidine on the peri-operative hemodynamic changes during CABG surgery.

NCT ID: NCT05778279 Recruiting - Clinical trials for Central Nervous System Diseases

Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies

Start date: September 30, 2024
Phase:
Study type: Observational

The fetal CNS screening examination during the mid-trimester scan in low-risk pregnancies should include evaluation of the fetal head and spine, using transabdominal sonography. Evaluation of two axial planes allows visualization of the relevant cerebral structures to assess the anatomic integrity of the fetal brain.These planes are commonly referred to as the transventricular and transcerebellar planes. A third plane, the so-called transthalamic plane, is frequently added, mostly for the purpose of biometry. Structures that should be noted in the routine examination include the lateral ventricles, the cerebellum, the cisterna magna, and the cavum septi pellucidi (CSP). Head shape and brain texture should also be noted on these views.

NCT ID: NCT05778084 Recruiting - Clinical trials for Heart Failure With Reduced Ejection Fraction

Effect of Empagliflozin on NT-Pro Brain Natriuretic Peptide in Heart Failure Patients With Reduced Ejection Fraction

Start date: December 15, 2022
Phase: Phase 4
Study type: Interventional

This study aims to evaluate the relationship between NT-proBNP and empagliflozin effects in patients with chronic heart failure with mildly reduced ejection fraction (HFmrEF 41-49%) and reduced ejection fraction (HFrEF ≤40%) whether diabetic or non-diabetic patients.

NCT ID: NCT05777837 Recruiting - Cesarean Scar Niche Clinical Trials

Laparoscopic Versus Combined Laparoscopic and Hysteroscopic Repair of CS Niche

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

Uterine niche is a frequent condition in patients with a history of cesarean section. Many treatment methods have been described for repair of niche with varying effectivities. In conventional Laparoscopic approach, not all bleeding points and fibrotic area are resected, while conventional hysteroscopic one result in more wide defect with high risk of recurrence and cannot be used in large niche with low RMT. In this new Double approach (hysteroscopy and laparoscopy) technique, the benefit of both laparoscopy and hysteroscopy will be attained.

NCT ID: NCT05777200 Recruiting - Clinical trials for Substance Use Disorders

Sociodemographic and Clinical Characteristics of Patients Admitted to the Addiction Management Unit

Start date: April 13, 2023
Phase:
Study type: Observational

Substance use disorder (SUD) is a dynamic process that changes constantly over time with new trends of drug dependence emerge every now and then, thus timely information about trends in psychoactive substance use could yield tailored interventions and reduce potential harms. Identifying personal, social, and demographic characteristics of patients with this disorder at the local, regional, and national levels helps physicians, health authorities, and policy-makers detect early emerging trends and enable them better plan and implement prevention, treatment, and rehabilitation programs. This study aims to identify sociodemographic, personal characteristics, as well as patterns of illicit drug abuse in patients admitted for addiction treatment.

NCT ID: NCT05775393 Recruiting - Post Operative Pain Clinical Trials

Effects of Adding Dexamethasone Plus Ketamine to Bupivacine in Serrtatus Plane Block

Start date: February 20, 2022
Phase: N/A
Study type: Interventional

This randomized, double-blind trial included 60 female patients undergoing modified radical mastectomy. The study carried out at National Cancer Institute, cairo university after approval of the local ethical committee. The study aiming to compare the analgesic efficiency of adding dexamethasone or ketamine plus dexamethasone to bupivacaine in ultrasound-guided serratus anterior plane block (SAPB) performed with modified radical mastectomy surgery.

NCT ID: NCT05773365 Recruiting - Pain Clinical Trials

PENG Block Plus Local Infiltration Compared to PENG Block Alone in Hip Surgery

Start date: July 18, 2023
Phase: N/A
Study type: Interventional

Summary: Pain control after hip surgery is quite important for patients' recovery. Many regional techniques are available with the focus on motor sparing block to speed patient recovery. The investigators will compare pericapsular nerve group (PENG) block in addition to local skin infiltration to PENG block alone. The study population will be included for patient traumatic hip surgery. The study population will be divided into group. First group will receive PENG block and local anaesthetics infiltration and second group will receive PENG block. Our primary outcome is to compare numeric rating scale (NRS) between studied groups, and morphine requirements in the first 24 hours as a secondary outcome.

NCT ID: NCT05773339 Recruiting - Clinical trials for Patients With Acute Upper Gastrointestinal Bleeding

Prognostic Value of AIMS65 Score to Predict Outcome in Patients With Acute Upper Gastrointestinal Bleeding

Start date: March 1, 2023
Phase:
Study type: Observational

Prognostic Value of AIMS65 Score to predict outcome in patients with acute upper gastrointestinal bleeding